Eli Lilly and Company

Indianapolis medicines company founded in 1876; won Jaypirca's first U.S. approval in mantle cell lymphoma in 2023 before expanding it through CLL/SLL's later lines and now the frontline setting.

lilly.com

6 stories

Regulatory News has published 6 stories about Eli Lilly and Company between 3 August 2026 and 5 October 2026, each sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 5 October 2026.

This page is generated from Regulatory News’ editorial coverage of Eli Lilly and Company. It is not an advertisement.

Products in our coverage

Our coverage

6 stories, newest first.

A physician in a white coat reviews a patient's chart on a clipboard

For Physicians FDA Approves Jaypirca for Frontline CLL/SLL Oct 5, 202610 min read Read the story

A physician in a white coat and stethoscope reviews a tablet with a patient during a clinic consultation

For Physicians FDA Approves Oral SERD Combo for ESR1+ Breast Cancer Sep 28, 20268 min read Read the story

A physician in a white coat and gloves checks a patient’s blood glucose with a meter during a consultation

For Physicians FDA Approves Onswik, Lilly's Once-Weekly Basal Insulin Sep 27, 202614 min read Read the story

A scientist in a white lab coat, blue gloves and safety glasses looks through a microscope in a laboratory

Drugs & Biologics FDA Approves Lilly's Inluriyo-Verzenio Combo Sep 20, 20266 min read Read the story

A smiling professional in glasses and a tweed blazer reads a printed document by a sunlit skylight window

Drugs & Biologics UK First in Europe to Approve Lilly's Foundayo Pill Aug 13, 20265 min read Read the story

A person signs a printed document by hand with a pen while a colleague stands nearby at a wooden table

Drugs & Biologics FDA Grants Breakthrough Status to Lilly's KRAS Drug Aug 3, 20264 min read Read the story

All companies